Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
Smigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X. | NeuroImage | 1 August 2019
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants
Sessa, B., Sakal, C., O’Brien, S., & Nutt, D. | BMJ Case Reports CP | 15 July 2019
Harnessing Neuroimaging to Enhance Our Understanding of the Effects of Ketamine in Depression.
Jaworska, N., & Phillips, J. L. | Cognitive neuroscience and neuroimaging | 1 July 2019
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 1 July 2019
Psychedelic crossings: American mental health and LSD in the 1970s.
Richert, L., & Dyck, E. | Medical Humanities | 23 June 2019
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 20 June 2019
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
Hashimoto, K. | Psychiatry and Clinical Neurosciences | 19 June 2019
Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Elliott, S. P., Dowling, G., ... & Halberstadt, A. L. | Drug testing and analysis | 18 June 2018
Replication and extension of a model predicting response to psilocybin
Russ, S. L., Carhart-Harris, R. L., Maruyama, G., & Elliott, M. S. | Psychopharmacology | 15 June 2019
Collective self-experimentation in patient-led research: How online health communities foster innovation
Kempner, J., & Bailey, J. | Social Science & Medicine | 11 June 2019